Intervention Review

Penicillamine for treating rheumatoid arthritis

  1. Maria E Suarez-Almazor1,*,
  2. Elaine Belseck2,
  3. Carol Spooner3

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 23 OCT 2000

Assessed as up-to-date: 29 AUG 2000

DOI: 10.1002/14651858.CD001460


How to Cite

Suarez-Almazor ME, Belseck E, Spooner C. Penicillamine for treating rheumatoid arthritis. Cochrane Database of Systematic Reviews 2000, Issue 4. Art. No.: CD001460. DOI: 10.1002/14651858.CD001460.

Author Information

  1. 1

    The University of Texas, M.D. Anderson Cancer Center, Department of General Internal Medicine, Houston, Texas, USA

  2. 2

    University of Alberta, Department of Pediatrics, Alberta, Canada

  3. 3

    1G1.52 Walter Mackenzie Health Centre, Division of Emergency Medicine, Edmonton, Alberta, Canada

*Maria E Suarez-Almazor, Department of General Internal Medicine, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1465, Houston, Texas, 77030, USA. msalmazor@mdanderson.org.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 23 OCT 2000

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Valeria A. Kostevich, Alexey V. Sokolov, Natalia A. Grudinina, Elena T. Zakharova, Valeria R. Samygina, Vadim B. Vasilyev, Interaction of macrophage migration inhibitory factor with ceruloplasmin: role of labile copper ions, BioMetals, 2015, 28, 5, 817

    CrossRef